REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,441,620 | +262.7% | 81,848 | +298.0% | 0.02% | +650.0% |
| Q1 2021 | $2,052,000 | -17.4% | 20,566 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $2,484,000 | +319.6% | 20,100 | +432.0% | 0.00% | – |
| Q2 2020 | $592,000 | +43.0% | 3,778 | +30.0% | 0.00% | – |
| Q1 2020 | $414,000 | +106.0% | 2,906 | +16.3% | 0.00% | – |
| Q3 2019 | $201,000 | -28.7% | 2,499 | -16.3% | 0.00% | – |
| Q2 2019 | $282,000 | -16.8% | 2,986 | -24.7% | 0.00% | – |
| Q1 2019 | $339,000 | +591.8% | 3,968 | +130.4% | 0.00% | – |
| Q4 2017 | $49,000 | – | 1,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |